5 subject must discontinue use of steroid muscle relaxant anticonvulsant sodium channel blocker topical analgesic and needle-based therapy include trigger point injection and acupuncture at least 1 week prior to start study medication and agree to stay off such therapy throughout the study continuation of nonsteroidal anti-inflammatory antidepressant and opiate be allow provide they have reach a stable dose prior to study entry and maintain a stable dose throughout the study 